AI assistant
Q32 Bio Inc. — Director's Dealing 2025
Aug 29, 2025
34891_dirs_2025-08-28_388de6f2-6962-4188-aabd-0f4c90b0e146.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2025-08-26
Reporting Person: Morrison Jodie Pope (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-26 | Common Stock | S | 10494 | $1.8010 | Disposed | 121506 | Direct |
Footnotes
F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
F2: The price reported is a weighted average price. The securities were sold in multiple transactions over two consecutive trading days, at per share prices ranging from $1.81 to $1.96 and $1.73 to $1.83, respectively. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2.